Ren Yuehan, Zhang Junning, Wu Weizhen, Yuan Yi, Wang Jiale, Tang Yi, Liao Yan, Liu Xinmin
Department of Gynaecology, China Academy of Chinese Medicine Sciences Guang'anmen Hospital, Beijing, China.
Graduate School, Beijing University of Chinese Medicine, Beijing, China.
Front Med (Lausanne). 2023 Dec 13;10:1268220. doi: 10.3389/fmed.2023.1268220. eCollection 2023.
Uterine fibroids (UFs) are the most common benign tumors in women of reproductive age. The most effective treatment is myomectomy, but there is no long-term or low-invasive treatment option exists. Acupuncture can be used to treat UFs in a variety of ways. However, there is no meta-analytic synthesis including valid data that explored the efficacy of acupuncture for UFs.
To assess the efficacy and safety of acupuncture for treating UFs.
The PRISMA 2020 checklist was used. We identified and extracted the trials through may 2023 from six databases. The quality of the trials was assessed using the risk of bias (2.0). Meta-analysis was performed using RevMan 5.4 software, and it was synthesized using the random-effects model if the included studies were in high heterogeneity. Subgroup and sensitivity analysis were used if necessary.
A total of 1,035 trials were identified, of which 11 were included in the review and meta-analysis. In terms of acupuncture scheme design and fibroid-related symptoms, the trials are highly heterogeneous. All 11 trials have reported acupuncture types, with traditional acupuncture and electroacupuncture being the more representative subgroups. A qualitative review of existing evidence shows that acupuncture has no serious adverse reaction on UFs. Meta-analysis shows that acupuncture can effectively reduce the volume of UFs (MD - 3.89, 95% CI - 5.23 to - 2.56, < 0.00001) or uterine volume (MD - 16.22, 95% CI - 19.89 To - 12.55, < 0.00001), reduce the score of fibroid symptoms (MD - 3.03, 95% CI - 3.45 to - 2.60, < 0.00001), improve the treatment efficiency (RR: 0.19, 95% CI: 0.13 to 0.25, < 0.00001), and likely do not affect the estrogen level.
子宫肌瘤(UFs)是育龄女性中最常见的良性肿瘤。最有效的治疗方法是子宫肌瘤切除术,但目前尚无长期或低侵入性的治疗选择。针灸可以多种方式用于治疗子宫肌瘤。然而,尚无包含有效数据的荟萃分析来探讨针灸治疗子宫肌瘤的疗效。
评估针灸治疗子宫肌瘤的疗效和安全性。
采用PRISMA 2020清单。我们从六个数据库中识别并提取截至2023年5月的试验。使用偏倚风险(2.0)评估试验质量。使用RevMan 5.4软件进行荟萃分析,若纳入研究异质性高,则采用随机效应模型进行综合分析。必要时进行亚组分析和敏感性分析。
共识别出1035项试验,其中11项纳入综述和荟萃分析。在针灸方案设计和肌瘤相关症状方面,试验具有高度异质性。所有11项试验均报告了针灸类型,传统针灸和电针是更具代表性的亚组。对现有证据的定性综述表明,针灸对子宫肌瘤无严重不良反应。荟萃分析表明,针灸可有效减小子宫肌瘤体积(MD - 3.89,95%CI - 5.23至 - 2.56,<0.00001)或子宫体积(MD - 16.22,95%CI - 19.89至 - 12.55,<0.00001),降低肌瘤症状评分(MD - 3.03,95%CI - 3.45至 - 2.60,<0.00001),提高治疗有效率(RR:0.19,95%CI:0.13至0.25,<0.00001),且可能不影响雌激素水平。